Indeed, the deletion of MR was shown to improve cardiac and coronary endothelial functions and reduce oxidative stress, thereby clarifying the role of VSMC-MR in worsening HF post-MI and identifying it as a potential therapeutic target. The gene discussed is NR3C2; the disease is hydrops fetalis.